GlassScriptPhysician profile
Ashley Wong
NPI 1841687472
$11,136.50
in general payments reported to CMS, 2019-2025
31 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,874 · 2020: $1,150 · 2021: $2,408 · 2022: $667 · 2023: $590 · 2024: $191 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,774.06 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $2,526.27 | 2019-2020 | |
| Abbvie INC. | $850.90 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Medtronic, INC. | $847.98 | 2021-2022 | |
| Abbott Laboratories | $274.54 | 2019-2023 | Eterna |
| Lilly USA, LLC | $221.48 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $172.08 | 2021 | |
| Saluda Medical Americas, INC. | $155.03 | 2023 | Evoke Scs |
| Biohaven Pharmaceuticals, INC. | $154.81 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $121.15 | 2024-2025 | Iqirvo |
| Si-Bone, INC. | $114.34 | 2025 | |
| Scilex Pharmaceuticals INC. | $110.47 | 2021-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $89.44 | 2021-2024 | Belbuca |
| Pacira Therapeutics, INC. | $87.95 | 2021 | |
| Spr Therapeutics, INC | $85.00 | 2023 | Sprint Pns System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $69.08 | 2021 | |
| Janssen Biotech, INC. | $67.43 | 2022-2023 | Simponi, Simponi Aria, Remicade |
| Kowa Pharmaceuticals America, INC. | $64.47 | 2022-2023 | Seglentis |
| Allergan, INC. | $63.20 | 2021 | |
| Redhill Biopharma INC. | $51.63 | 2021 | |
| Amgen INC. | $47.54 | 2021 | |
| Forte Bio-Pharma LLC | $30.41 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.21 | 2022 | |
| Vertos Medical, INC. | $20.12 | 2023 | Mild Device Kit |
| Ibsa Pharma INC. | $19.15 | 2021 | |
| Pfizer INC. | $18.34 | 2021 | |
| Painteq LLC | $17.12 | 2024 | Painteq |
| Stimwave Technologies Incorporated | $16.16 | 2021 | |
| Nalu Medical, INC. | $15.95 | 2021 | |
| Globus Medical, INC. | $15.30 | 2025 | Senza |
| Nevro Corp. | $13.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.